[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-352982-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-352982-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","identification-and-characterization-of-cancer-related-risk-metabolic-subpathways-reveal-their-functional-significance-in-cancer","Identification and Characterization of Cancer-Related Risk Metabolic Subpathways Reveal Their Functional Significance in Cancer","","Cancer progression is accompanied by significant metabolic alterations. We developed a novel computational approach to identify cancer-related risk metabolic subpathways (CMSubpathway). Leveraging the topology of large-scale metabolic pathway gene networks, the method first infers candidate subpathways, then refines them using pathway activity dysregulation, prognostic efficacy, and classification performance. Across 21 cancer types, 12 risk metabolic subpathways in six cancers were identified, forming core metabolic module genes.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/identification-and-characterization-of-cancer-related-risk-metabolic-subpathways-reveal-their-functional-significance-in-cancer/352982/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/identification-and-characterization-of-cancer-related-risk-metabolic-subpathways-reveal-their-functional-significance-in-cancer/352982.png","ImageObject",300,407,{"name":42,"@type":43},"Pentious","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-13","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is CMSubpathway and what does it do?","Question",{"text":63,"@type":64},"CMSubpathway is a computational approach for identifying cancer-related risk metabolic subpathways. It refines candidates by integrating pathway activity dysregulation, prognostic efficacy, and classification performance.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How many risk metabolic subpathways were identified, and in which cancers?",{"text":68,"@type":64},"The study identified 12 risk metabolic subpathways in six cancer types after screening across 21 cancer types.",{"name":70,"@type":61,"acceptedAnswer":71},"Which biological module genes were validated using CRISPR knockout screening?",{"text":72,"@type":64},"The authors used DepMap public CRISPR knockout screening data to support essential roles of ADH5, ALDH1B1, and ALDH7A1 in breast cancer cell growth and development.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},352982,1791069654,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1374404730887,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Article  \nIdentification and Characterization of Cancer-Related Risk Metabolic Subpathways Reveal Their Functional Significance in Cancer  \nHongying Zhao 1,†, Jinxing Yan 1,†, Ming Wu 1, Shiyi Li 1, Weiming He 2, Xiangzhe Yin 1, Wangyang Liu 1, Ying Liu 1, Meiting Fei 1, Wan Li 1, Junjie Lv 1, Lina Chen 1,* and Li Wang 1, *  \nAcademic Editor: Luca Agnelli  \nReceived: 7 March 2026  \nRevised: 5 May 2026  \nAccepted: 6 May 2026  \nPublished: 10 May 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 College of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150081, China; [zhaohongying@hrbmu.edu.cn](zhaohongying@hrbmu.edu.cn) (H.Z.); [yanjinxing0712@163.com](yanjinxing0712@163.com) (J.Y.); [wm734393188@163.com](wm734393188@163.com) (M.W.); [lsyshea@163.com](lsyshea@163.com) (S.L.); [yxzswyxgc@163.com](yxzswyxgc@163.com) (X.Y.); [liuwangyang2022@163.com](liuwangyang2022@163.com) (W.L.); [liuying2022020510@163.com](liuying2022020510@163.com) (Y.L.); [fmt2844143432@163.com](fmt2844143432@163.com) (M.F.)  \n2 Institute of Opto-Electronics, Harbin Institute of Technology, Harbin 150000, China; [hewm@hit.edu.cn](hewm@hit.edu.cn)  \n* Correspondence: [chenlina@ems.hrbmu.edu.cn](chenlina@ems.hrbmu.edu.cn) (L.C.); [wangli@hrbmu.edu.cn](wangli@hrbmu.edu.cn) (L.W.)† These authors contributed equally to this work.  \nAbstract  \nCancer progression is accompanied by significant metabolic alterations. We developed a novel computational approach to identify cancer-related risk metabolic subpathways (CMSubpathway) . By leveraging the topology of large-scale metabolic pathway gene networks, we initially identified metabolic subpathways and then refined them by taking into account pathway activity dysregulation, prognostic efficacy, and classification performance. We employed the CMSubpathway to extensively identify cancer-related metabolic subpathways across 21 cancer types. Ultimately, 12 risk metabolic subpathways were identified in six cancer types. Subsequently, the 12 overlapping genes of risk metabolic subpathways were identified as the core metabolic module genes. Utilizing the public CRISPR knockout screening datasets sourced from DepMap, we further supported our hypothesis that the essential roles of ADH5, ALDH1B1, and ALDH7A1 in breast cancer cell growth and development. The core metabolic module and its associated genes exhibited significant down-regulation at both the transcriptome and proteome levels based on data from tissues, blood, and single cells. The activity of this core metabolic module was associated with the immune infiltration levels of multiple immune cells, especially T cells. Notably, an abnormal core metabolic module was observed in CD8 T cell subtypes, with the stem-like CD8 T cell subtype showing high metabolic activity and exhaustion markers. Thus, we established a method for identifying risk metabolic subpathways in cancers, which helps to identify more precise biomarkers for cancer patients.  \nKeywords: subpathways; biomarkers; metabolism  \n1. Introduction  \nThe reprogramming of metabolism, the process of tumor cells reprogramming metabolic pathways to meet the energy and biosynthetic demands of tumor cells in order to adapt to hypoxia and nutrient deficiency, is a hallmark of malignancy with great potential for prognosis and targeted therapy [1] . For example, the abnormal activation andreprogramming of multiple key metabolic pathways, such as glycolysis, fatty acid synthesis, and amino acid metabolism, are considered to be one of the key factors promoting  \ntumor progression in breast cancer [2] . Recently, an increasing number of studies have reported that abnormalities in mRNA, proteins, and metabolites play important roles in metabolic reprogramming in cancer. For instance, the study by Torresano et al. identified the up-regulatio","cbCaitAstN9qkGnJ","https://ap.wps.com/l/cbCaitAstN9qkGnJ","pdf",8053020,22,"English","# Introduction\n# Methods\n# Results\n## Risk metabolic subpathways across cancer types\n## Core metabolic module and validation\n## Associations with immune infiltration\n# Discussion","[{\"question\":\"What is CMSubpathway and what does it do?\",\"answer\":\"CMSubpathway is a computational approach for identifying cancer-related risk metabolic subpathways. It refines candidates by integrating pathway activity dysregulation, prognostic efficacy, and classification performance.\"},{\"question\":\"How many risk metabolic subpathways were identified, and in which cancers?\",\"answer\":\"The study identified 12 risk metabolic subpathways in six cancer types after screening across 21 cancer types.\"},{\"question\":\"Which biological module genes were validated using CRISPR knockout screening?\",\"answer\":\"The authors used DepMap public CRISPR knockout screening data to support essential roles of ADH5, ALDH1B1, and ALDH7A1 in breast cancer cell growth and development.\"}]","Identification and Characterization of Cancer-Related Risk Metabolic Subpathways Reveal Their Functional Significance in Cancer | PDF",1790102410,55,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7e109146fbf22572afc657d5ffcd1a2a.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a127bd7815ff9a365a3d0de661f663bc.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d531c97ecac35782e220cedcf668415b.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d481a379934223393438892aa85f5782.webp",980,1385]